Aleafia Health Inc and Cronos Group Inc have launched a joint medical cannabis study to improve the management and treatment of insomnia and daytime sleepiness.
The study is funded in part by Peace Naturals Project Inc, a licensed producer of medical cannabis that is wholly owned by Cronos Group. The study will be led by physicians practicing within the Canabo Medical Clinic network, which is wholly owned by Aleafia.
“Aleafia is excited to participate in a study with Cronos Group, a company with a firm commitment to patient health. For far too long, the answer to a patient’s sleeping disorder or chronic pain has been a prescription and a bottle of pills,” says Aleafia chief medical officer Michael Verbora,MBA, MD, CCFP, in a release. “There is mounting evidence of the risks of prescription sleeping aids including worsening mental health and increased risk of dementia. This study may in part point to medical cannabis as an alternative to harmful prescription drugs.”
Mike Gorenstein, CEO of Cronos Group, says, “The negative health impacts of sleep disorders and their proper treatment must be more widely acknowledged and understood. Cronos Group is pleased to find a partner in Aleafia that shares our commitment to addressing this overlooked public health issue.”
